Where to buy Nilotinib

Nilotinib (Nilotinib) is an oral second-generation transduction inhibitor that targets BCR-ABL, c-kit and PDGF. It is suitable for the treatment of adults with imatinib-resistant or intolerant Ph+CML-CP and -AP (chronic phase and accelerated phase Philadelphia chromosome-positive chronic myelogenous leukemia).

Positive clinical activity and tolerability were reported in clinical trials. Clinical data are emerging regarding off-label indications and in patients with Ph+ ALL and gastrointestinal stromal tumors (GIST). Nilotinib is an orally bioavailable derivative of imatinib with improved specificity for the breakpoint cluster region-Abelson murine leukemia (BCR-ABL) viral proto-oncogene. In preclinical studies, nilotinib was found to be active against 32 of 33 imatinib-resistant BCR-ABL mutations, but not against the T3151 mutation.

The original drug Nilotinib is marketed in China under the name Nilotinib and is covered by medical insurance, but it is only reimbursed for patients who meet the indications. Specifications The price of 150mg*120 capsules per box may be around 9,000 yuan. This drug may be sold in domestic hospitals or pharmacies, but it must be purchased and used under the guidance of a doctor with a prescription. The price of the Indian version of Nilotinib's original drug, 150mg*28 capsules, per box sold overseas may be around RMB 1,000 (the price may fluctuate due to the exchange rate). The ingredients of the original drug sold domestically and abroad are basically the same. There is currently no generic version of Nilotinib on the market. For more information and specific prices on purchasing overseas drugs, please consult a medical consultant.